Can brain scans help predict glioblastoma progression?
Part of Cancer clinical trials.
This trial is testing whether certain details on brain scans can help doctors better predict how brain cancer (glioblastoma) will progress. You may be eligible if you are newly diagnosed with this type of cancer and plan to receive standard treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been newly diagnosed with a type of brain tumor called glioblastoma (GBM) that is IDH wild-type.
- You plan to receive standard treatment for your glioblastoma.
- You have had an MRI scan before your surgery and another one within 3 weeks after surgery, and both images can be shared.
- You are able to have an MRI with contrast dye and have no allergies to the special imaging agents used in this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether special MRI scans and blood tests can help tell the difference between true tumor growth (progression) and a treatment-related reaction called 'pseudoprogression' in people with glioblastoma. The goal is to make treatment decisions more accurate.
This trial tests whether artificial intelligence can help plan radiation therapy better for people with a type of brain cancer called glioblastoma. It may lead to more precise treatment and fewer side effects.
This study uses special MRI imaging with deuterium to see how radiotherapy affects newly diagnosed glioblastoma (GBM) with an IDH-wildtype tumor. It may help doctors better understand treatment response and timing, potentially improving how radiotherapy is planned.
This trial tests whether using advanced MRI scans before radiation therapy can help doctors target the tumor more precisely and possibly improve outcomes for people with glioblastoma. It aims to make radiation treatment more personalized.
This study uses MRI scans to predict key genetic markers and outcomes in people with high-grade gliomas (aggressive brain tumors). If you are between 18 and 70 years old and have been diagnosed or are suspected of having a high-grade glioma, this research may help better understand your tumor without extra procedures.
This study tests whether imaging scans can be timed based on your symptoms and progress, rather than on a fixed schedule. The goal is to make monitoring easier while keeping you safe during standard brain cancer treatment.
Hear when a new Glioblastoma, IDH-wildtype trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.